Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07536607

Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients

Prospective Study ofPhoton Counting Computed Tomography in Acute Coronary Syndrom Patients

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

For patients with severe calcification or complex non-calcified plaques, we investigate wether PCCT can enable non-invasive, in vivo precise differentiation and quantitative measurement of plaque components (e.g., spotty calcification, necrotic core, fibrous tissue). Further we also study wether these quantitative imaging features can independently predict the risk of MACE in the short term and long term

Detailed description

Photon-counting detector CT (PCD-CT), as an innovative technology in the field of CT imaging, is gradually transforming the landscape of cardiac imaging. It differs significantly from conventional energy-integrating detector CT (EID-CT) in technical principles, bringing new possibilities for the diagnosis and assessment of heart diseases. This study will enrolled patients undergo standardized PCCT coronary angiography (CCTA) and make ultra-fine quantitative plaque analysis. Then at least 12 months of clinical follow-up will be performed. Finally correlation analysis between baseline plaque characteristics and follow-up endpoint events will be made.

Conditions

Interventions

TypeNameDescription
OTHERthere is no intervention in this studythere is no intervention

Timeline

Start date
2026-04-20
Primary completion
2027-04-20
Completion
2028-12-01
First posted
2026-04-17
Last updated
2026-04-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07536607. Inclusion in this directory is not an endorsement.